NL-OMON45142招募中3 期
Prophylactic Cranial Irradiation with or without hippocampal avoidance in SCLC: a randomized phase III study - HA-PCI
ederlands Kanker Instituut0 个研究点目标入组 125 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •* SCLC patients (stage I-III or stage IV without clinical or radiological evidence of brain metastases) candidate for PCI, i.e. without progressive disease after chemo-radiotherapy in stage I-III or after a remission after chemotherapy in stage IV
- •* WHO-performance status * 2(see Appendix IV).
- •* Sufficient proficiency in Dutch language
- •* Written informed consent must be given according to ICH/GCP, national and local regulations
排除标准
- •* Prior radiotherapy to the brain
- •* clinical evidenceof brain metastases or primary brain tumors
- •* Evidence of progressive extracranial metastatic disease
- •* Previous malignancy < 2 years ago except for adequately treated basal cell carcinoma of the skin and carcinoma in situ of the cervix
- •* Any systemic anticancer treatment during PCI or within 3 weeks before start PCI.
- •* Pregnancy or lactation
研究者
相似试验
招募中
2 期
Prophylactic cranial irradiation with hippocampal sparing technique in small cell lung cancer patientsPatients who is diagnosed small cell lung cancer and fulfilled criterion for prophylactic cranial irradiation will be enrolled to this studyhippocampal sparing,prophylactic cranial irradiation,small cell lung cancerTCTR20200725001Faculty of Medicine, Chiang Mai University25
招募中
3 期
Prophylactic Cranial Irradiation (PCI) versus observation in radically treated patients with stage III non-small cell lung cancer: A phase III randomized study (NVALT-11/ DLCRG-02).10038666lung cancerNL-OMON35252ederlandse Vereniging van artsen voor Longziekten en Tuberculose450
已完成
3 期
Hippocampus Avoidance PCI vs PCILung CancerSmall Cell Lung CancerNCT01780675The Netherlands Cancer Institute168
招募中
不适用
Prophylactic Cranial Irradiation (PCI) versus observation in radically treated patients with stage III non-small cell lung cancer: A phase III randomized study.on small cell lung cancer (NSCLC).Patients should either be registered after diagnosis of stage III NSCLC, when potential radical therapy is envisaged, or after radical therapy. After radical treatment, non-progressing patients will be randomized to receive PCI of no PCI.NL-OMON25846VALT-oncology en DLCRG300
已完成
不适用
Fatigue after prophylactic cranial irradiation in stage I-III small cell lung cancer patients: is there a substrate on functional magnetic resonance imaging of the brain?kleincellig longkanker patienten die profylactische schedelbestraling krijgenfatiguesmall-cell lung cancer10029107NL-OMON41049Medisch Universitair Ziekenhuis Maastricht46
